{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:10:49Z","timestamp":1790043049903,"version":"4.0.1"},"reference-count":14,"publisher":"Royal College of Psychiatrists","issue":"6","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":1676,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>One in four patients with schizophrenia responds poorly to antipsychotic medication, continuing to hear persecutory auditory hallucinations. Patients who are able to sustain a dialogue with their persecutor feel much more in control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To develop a computerised system that enables the patient to create an avatar of their persecutor. To encourage them to engage in a dialogue with the avatar, which the therapist is able to control so that the avatar progressively yields control to the patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Avatar therapy was evaluated by a randomised, single blind, partial crossover trial comparing the novel therapy with treatment as usual (TAU). We used three main outcome measures: (a) the Psychotic Symptom Rating Scale (PSYRATS), hallucinations section; (b) the Omnipotence and Malevolence subscales of the Revised Beliefs About Voices Questionnaire (BAVQ-R); and (c) the Calgary Depression Scale (CDS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The control group showed no change over time in their scores on the three assessments, whereasthe novel therapy group showed mean reductions in the total PSYRATS score (auditory hallucinations) of 8.75 (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003) and in the BAVQ-R combined score of omnipotence and malevolence of the voices of 5.88 (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.004). There was no significant reduction in the CDS total score for depression. For the crossover control group, comparison of the period of TAU withthe period ofavatar therapy confirmed the findings of the previous analysis. The effect size of the therapy was 0.8.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Avatar therapy represents a promising treatment for medication-resistant auditory hallucinations. Replication with a larger sample is required before roll-out to clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1192\/bjp.bp.112.124883","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T22:37:37Z","timestamp":1361486257000},"page":"428-433","source":"Crossref","is-referenced-by-count":183,"title":["Computer-assisted therapy for medication-resistant auditory hallucinations: proof-of-concept study"],"prefix":"10.1192","volume":"202","author":[{"given":"Julian","family":"Leff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Huckvale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Arbuthnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex P.","family":"Leff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000274710_ref10","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291799008661","article-title":"Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales","volume":"29","author":"Haddock","year":"1999","journal-title":"Psychol Med"},{"key":"S0007125000274710_ref12","doi-asserted-by":"crossref","first-page":"s39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the Calgary Depression Scale","volume":"163","author":"Addington","year":"1993","journal-title":"Br J Psychiatry"},{"key":"S0007125000274710_ref1","first-page":"35","article-title":"Treatment resistant schizophrenic patients","volume":"57","author":"Kane","year":"2007","journal-title":"J Clin Psychol"},{"key":"S0007125000274710_ref9","doi-asserted-by":"crossref","DOI":"10.1109\/89.661472","article-title":"Continuous probabilistic transform for voice conversion","volume":"6","author":"Stylianou","year":"1998","journal-title":"IEEE Trans Speech and Audio Proc"},{"key":"S0007125000274710_ref4","volume-title":"Living with Voices: 50 Stories of Recovery","author":"Romme","year":"2009"},{"key":"S0007125000274710_ref3","doi-asserted-by":"crossref","DOI":"10.1017\/S003329170003381X","article-title":"The auditory hallucination: a phenomenological survey","volume":"26","author":"Nayani","year":"1996","journal-title":"Psychol Med"},{"key":"S0007125000274710_ref7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17522439.2011.571705","article-title":"Talking with voices: exploring what is expressed by the voices people hear","volume":"4","author":"Corstens","year":"2012","journal-title":"Psychosis"},{"key":"S0007125000274710_ref14","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-09-3287","article-title":"The design of Phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical design task force of the national cancer institute investigational drug steering committee","volume":"16","author":"Seymour","year":"2010","journal-title":"Clin Cancer Res"},{"key":"S0007125000274710_ref11","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.177.3.229","article-title":"The revised Beliefs About Voices Questionnaire (BAVQ-R)","volume":"177","author":"Chadwick","year":"2000","journal-title":"Br J Psychiatry"},{"key":"S0007125000274710_ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.bp.110.083642","article-title":"Childhood sexual abuse and psychosis: data from a cross-sectional national psychiatric survey in England","volume":"199","author":"Bebbington","year":"2011","journal-title":"Br J Psychiatry"},{"key":"S0007125000274710_ref5","doi-asserted-by":"crossref","DOI":"10.3371\/CSRP.2.3.5","article-title":"Child maltreatment and psychosis: a return to a genuinely integrated bio-psychosocial model","volume":"2","author":"Read","year":"2008","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"S0007125000274710_ref2","article-title":"Schizophrenia","volume":"374","author":"van","year":"2009","journal-title":"Lancet"},{"key":"S0007125000274710_ref8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1192\/bjp.164.2.190","article-title":"The omnipotence of voices, a cognitive approach to auditory hallucinations","volume":"164","author":"Chadwick","year":"1994","journal-title":"Br J Psychiatry"},{"key":"S0007125000274710_ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0920-9964(88)90036-9","article-title":"The clinical course of depressive symptoms in schizophrenia","volume":"1","author":"Leff","year":"1988","journal-title":"Schizophr Res"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000274710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T08:00:43Z","timestamp":1611129643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000274710\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0007125000274710"],"URL":"https:\/\/doi.org\/10.1192\/bjp.bp.112.124883","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985442.793484431","asserted-by":"object"}]},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}